{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:07:41Z","timestamp":1791439661514,"version":"4.3.3"},"reference-count":72,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>Migraine affects 959\u2009million people worldwide,1 with the highest prevalence being in women of childbearing age. The interplay between female hormones and migraine can be a challenging area to navigate since issues relating to pregnancy, contraception and the menopause are often out of the neurology comfort zone. This review aims to help the neurologist to manage women with migraine, from menarche to menopause.<\/jats:p>","DOI":"10.1136\/practneurol-2019-002332","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T22:19:32Z","timestamp":1574374772000},"page":"115-121","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Migraine: navigating the hormonal minefield"],"prefix":"10.1136","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8487-5677","authenticated-orcid":false,"given":"Shazia K","family":"Afridi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"2020070604550637000_20.2.115.1","doi-asserted-by":"crossref","unstructured":"Steiner TJ , Stovner LJ , Vos T . GBD 2015: migraine is the third cause of disability in under 50S. J Headache Pain 2016;17:104.doi:10.1186\/s10194-016-0699-5","DOI":"10.1186\/s10194-016-0699-5"},{"key":"2020070604550637000_20.2.115.2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt320"},{"key":"2020070604550637000_20.2.115.3","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.8.1270"},{"key":"2020070604550637000_20.2.115.4","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00034.2015"},{"key":"2020070604550637000_20.2.115.5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/117.1.199"},{"key":"2020070604550637000_20.2.115.6","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21"},{"key":"2020070604550637000_20.2.115.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00309.x"},{"key":"2020070604550637000_20.2.115.8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0333102417739584","article-title":"Gender aspects of CGRP in migraine","volume":"39","author":"Labastida-Ram\u00edrez","year":"2019","journal-title":"Cephalalgia"},{"key":"2020070604550637000_20.2.115.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00768-9"},{"key":"2020070604550637000_20.2.115.10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0333102417690891","article-title":"Estrogen-Dependent effects of 5-hydroxytryptophan on cortical spreading depression in rat: modelling the serotonin-ovarian hormone interaction in migraine aura","volume":"38","author":"Chauvel","year":"2018","journal-title":"Cephalalgia"},{"key":"2020070604550637000_20.2.115.11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13311-018-0616-5","article-title":"Glutamate and its receptors as therapeutic targets for migraine","volume":"15","author":"Hoffmann","year":"2018","journal-title":"Neurotherapeutics"},{"key":"2020070604550637000_20.2.115.12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.pain.2012.12.019","article-title":"The role of circulating sex hormones in menstrual cycle\u2013dependent modulation of pain-related brain activation","volume":"154","author":"Veldhuijzen","year":"2013","journal-title":"Pain"},{"key":"2020070604550637000_20.2.115.13","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000133134.68143.2E"},{"key":"2020070604550637000_20.2.115.14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.22.4.355"},{"key":"2020070604550637000_20.2.115.15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/WNL.0000000000002798","article-title":"Sex hormones in women with and without migraine: evidence of migraine-specific hormone profiles","volume":"87","author":"Pavlovic","year":"2016","journal-title":"Neurology"},{"key":"2020070604550637000_20.2.115.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1977.hed1703113.x"},{"key":"2020070604550637000_20.2.115.17","doi-asserted-by":"publisher","DOI":"10.1111\/head.13082"},{"key":"2020070604550637000_20.2.115.18","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000134620.30129.D6"},{"key":"2020070604550637000_20.2.115.19","doi-asserted-by":"crossref","unstructured":"de Ligni\u00e8res B , Vincens M , Mauvais-Jarvis P , et al . Prevention of menstrual migraine by percutaneous oestradiol. BMJ 1986;293:1540.doi:10.1136\/bmj.293.6561.1540","DOI":"10.1136\/bmj.293.6561.1540"},{"key":"2020070604550637000_20.2.115.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1990.hed3011705.x"},{"key":"2020070604550637000_20.2.115.21","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415584308"},{"key":"2020070604550637000_20.2.115.22","doi-asserted-by":"crossref","unstructured":"Grazzi L , Egeo G , Calhoun AH , et al . Non-Invasive vagus nerve stimulation (nVNS) as mini-prophylaxis for menstrual\/menstrually related migraine: an open-label study. J Headache Pain 2016;17:91.doi:10.1186\/s10194-016-0684-z","DOI":"10.1186\/s10194-016-0684-z"},{"key":"2020070604550637000_20.2.115.23","doi-asserted-by":"publisher","DOI":"10.1111\/head.12035"},{"key":"2020070604550637000_20.2.115.24","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84a.16033"},{"key":"2020070604550637000_20.2.115.25","unstructured":"Healthcare Fohasr . Clinical guidance: drug interactions with hormonal contraception. secondary clinical guidance: drug interactions with hormonal contraception, 2017. Available: https:\/\/www.fsrh.org\/standards-and-guidance\/documents\/ceu-clinical-guidance-drug-interactions-with-hormonal\/"},{"key":"2020070604550637000_20.2.115.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70266-6"},{"key":"2020070604550637000_20.2.115.27","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000129789.58837.e4"},{"key":"2020070604550637000_20.2.115.28","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000154528.21485.3A"},{"key":"2020070604550637000_20.2.115.29"},{"key":"2020070604550637000_20.2.115.30","doi-asserted-by":"crossref","unstructured":"Sacco S , Merki-Feld GS , \u00c6gidius KL , et al . Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European headache Federation (EHF) and the European Society of contraception and reproductive health (ESC). J Headache Pain 2017;18:108.doi:10.1186\/s10194-017-0815-1","DOI":"10.1186\/s10194-017-0815-1"},{"key":"2020070604550637000_20.2.115.31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2015.04.021","article-title":"Current use of oral contraceptives and the risk of first-ever ischemic stroke: a meta-analysis of observational studies","volume":"136","author":"Xu","year":"2015","journal-title":"Thromb Res"},{"key":"2020070604550637000_20.2.115.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1993.hed3307385.x"},{"key":"2020070604550637000_20.2.115.33","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100006028"},{"key":"2020070604550637000_20.2.115.34","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1999.3909625.x"},{"key":"2020070604550637000_20.2.115.35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00480.x"},{"key":"2020070604550637000_20.2.115.36","doi-asserted-by":"publisher","DOI":"10.1080\/14767050500260566"},{"key":"2020070604550637000_20.2.115.37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/head.13536","article-title":"Pregnancy, birth, neonatal, and postnatal neurological outcomes after pregnancy with migraine","volume":"59","author":"Skajaa","year":"2019","journal-title":"Headache"},{"key":"2020070604550637000_20.2.115.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01935.x"},{"key":"2020070604550637000_20.2.115.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01704.x"},{"key":"2020070604550637000_20.2.115.40","doi-asserted-by":"crossref","unstructured":"Penzien DB , Irby MB , Smitherman TA , et al . Well-Established and empirically supported behavioral treatments for migraine. Curr Pain Headache Rep 2015;19:34.doi:10.1007\/s11916-015-0500-5","DOI":"10.1007\/s11916-015-0500-5"},{"key":"2020070604550637000_20.2.115.41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","article-title":"Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders","volume":"168","author":"Liew","year":"2014","journal-title":"JAMA Pediatr"},{"key":"2020070604550637000_20.2.115.42","unstructured":"FDA . Fda has reviewed possible risks of pain medicine use during pregnancy drug safety communications 2015."},{"key":"2020070604550637000_20.2.115.43","doi-asserted-by":"crossref","unstructured":"Li D-K , Liu L , Odouli R . Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368.doi:10.1136\/bmj.327.7411.368","DOI":"10.1136\/bmj.327.7411.368"},{"key":"2020070604550637000_20.2.115.44","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.130605"},{"key":"2020070604550637000_20.2.115.45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278343"},{"key":"2020070604550637000_20.2.115.46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/01443615.2012.734871","article-title":"Fetal and neonatal outcomes in women taking domperidone during pregnancy","volume":"33","author":"Choi","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"2020070604550637000_20.2.115.47","unstructured":"FDA . Fda drug safety communication: antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns 2011."},{"key":"2020070604550637000_20.2.115.48","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/head.12500","article-title":"Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis","volume":"55","author":"Marchenko","year":"2015","journal-title":"Headache"},{"key":"2020070604550637000_20.2.115.49","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/0333102417724152","article-title":"Pregnancy outcome after anti-migraine triptan use: a prospective observational cohort study","volume":"38","author":"Spielmann","year":"2018","journal-title":"Cephalalgia"},{"key":"2020070604550637000_20.2.115.50","first-page":"1004","article-title":"Emergency department and inpatient management of status migrainosus and intractable headache","volume":"21","author":"Rozen","year":"2015","journal-title":"Continuum"},{"key":"2020070604550637000_20.2.115.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.01.016"},{"key":"2020070604550637000_20.2.115.52","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/AOG.0000000000000555","article-title":"Peripheral nerve blocks in the treatment of migraine in pregnancy","volume":"124","author":"Govindappagari","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2020070604550637000_20.2.115.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2014.06.055"},{"key":"2020070604550637000_20.2.115.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2010.02.007"},{"key":"2020070604550637000_20.2.115.55","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.158.4.312"},{"key":"2020070604550637000_20.2.115.56","doi-asserted-by":"crossref","first-page":"e703","DOI":"10.7205\/MILMED-D-13-00477","article-title":"OnabotulinumtoxinA successfully used as migraine prophylaxis during pregnancy: a case report","volume":"179","author":"Robinson","year":"2014","journal-title":"Mil Med"},{"key":"2020070604550637000_20.2.115.57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijgo.2008.11.033","article-title":"Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia","volume":"105","author":"Teran","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"2020070604550637000_20.2.115.58","doi-asserted-by":"crossref","unstructured":"Bhola R , Kinsella E , Giffin N , et al . Single-Pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain 2015;16:535.doi:10.1186\/s10194-015-0535-3","DOI":"10.1186\/s10194-015-0535-3"},{"key":"2020070604550637000_20.2.115.59","doi-asserted-by":"crossref","unstructured":"Wells RE , Turner DP , Lee M , et al . Managing migraine during pregnancy and lactation. Curr Neurol Neurosci Rep 2016;16:40.doi:10.1007\/s11910-016-0634-9","DOI":"10.1007\/s11910-016-0634-9"},{"key":"2020070604550637000_20.2.115.60","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.39412.x"},{"key":"2020070604550637000_20.2.115.61","doi-asserted-by":"publisher","DOI":"10.1111\/head.12064"},{"key":"2020070604550637000_20.2.115.62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0890334416680176","article-title":"Enhancing human milk production with domperidone in mothers of preterm infants","volume":"33","author":"Asztalos","year":"2017","journal-title":"J Hum Lact"},{"key":"2020070604550637000_20.2.115.63","unstructured":"Agency EM . Restrictions on the use of domperidone-containing medicines 2014."},{"key":"2020070604550637000_20.2.115.64","doi-asserted-by":"publisher","DOI":"10.1007\/BF00542527"},{"key":"2020070604550637000_20.2.115.65","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2003.03092.x"},{"key":"2020070604550637000_20.2.115.66","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1999.019002124.x"},{"key":"2020070604550637000_20.2.115.67","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013052"},{"key":"2020070604550637000_20.2.115.68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2053369117731172","article-title":"Menopause and hormone replacement therapy","volume":"24","author":"Migraine","year":"2018","journal-title":"Post Reprod Health"},{"key":"2020070604550637000_20.2.115.69","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181a8c84f"},{"key":"2020070604550637000_20.2.115.70","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","article-title":"The pathophysiology of migraine: implications for clinical management","volume":"17","author":"Charles","year":"2018","journal-title":"The Lancet Neurology"},{"key":"2020070604550637000_20.2.115.71","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-012-0424-y"},{"key":"2020070604550637000_20.2.115.72","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1753495X18769170","article-title":"Current concepts in migraine and their relevance to pregnancy","volume":"11","author":"Afridi","year":"2018","journal-title":"Obstet Med"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/practneurol-2019-002332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T11:56:53Z","timestamp":1594036613000},"score":1,"resource":{"primary":{"URL":"http:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/practneurol-2019-002332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":72,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,3,17]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1136\/practneurol-2019-002332"],"URL":"https:\/\/doi.org\/10.1136\/practneurol-2019-002332","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]}}}